Tosk: Funding, Investors & Team (Sep 2026)
Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.
Tosk has raised $100k across 1 funding round on record, the most recent a Debt Financing of $100k announced in Sep 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tosk Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Tosk Funding Rounds
Tosk Founders and Leadership Team
Contact details for the Tosk team: 1 of 1 has an email address on file.
Start 14-day free trial →Tosk Funding Compared to Other Biotechnology Startups
Tosk's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tosk in Biotechnology and Sunnyvale
Companies Similar to Tosk
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Tosk Funding FAQs
What does Tosk do?
Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.
How much funding has Tosk raised?
Tosk has raised $100k across 1 round on record. The most recent is a Debt Financing of $100k announced in Sep 2022.
When did Tosk last raise funding?
Tosk's most recent funding round on record is a Debt Financing of $100k, announced in Sep 2022.
Who is the CEO of Tosk?
Brian Frenzel is listed as CEO at Tosk.
Where is Tosk headquartered?
Tosk is based in Sunnyvale, California, United States.
How many employees does Tosk have?
Tosk is in the 11-50 employee band.
How does Tosk's funding compare to other Biotechnology startups?
Tosk's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Tosk Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tosk is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.